Authors: HARASYM TO BALLY MB TARDI P

Citation: To. Harasym et al., CLEARANCE PROPERTIES OF LIPOSOMES INVOLVING CONJUGATED PROTEINS FOR TARGETING, Advanced drug delivery reviews, 32(1-2), 1998, pp. 99-118

Authors: HARASYM TO CULLIS PR BALLY MB

Citation: To. Harasym et al., INTRATUMOR DISTRIBUTION OF DOXORUBICIN FOLLOWING IV ADMINISTRATION OFDRUG ENCAPSULATED IN EGG PHOSPHATIDYLCHOLINE CHOLESTEROL LIPOSOMES/, Cancer chemotherapy and pharmacology, 40(4), 1997, pp. 309-317

Authors: MAYER LD DOUGHERTY G HARASYM TO BALLY MB

Citation: Ld. Mayer et al., THE ROLE OF TUMOR-ASSOCIATED MACROPHAGES IN THE DELIVERY OF LIPOSOMALDOXORUBICIN TO SOLID MURINE FIBROSARCOMA TUMORS, The Journal of pharmacology and experimental therapeutics, 280(3), 1997, pp. 1406-1414

Authors: TARDI PG SWARTZ EN HARASYM TO CULLIS PR BALLY MB

Citation: Pg. Tardi et al., AN IMMUNE-RESPONSE TO OVALBUMIN COVALENTLY COUPLED TO LIPOSOMES IS PREVENTED WHEN THE LIPOSOMES USED CONTAIN DOXORUBICIN, Journal of immunological methods, 210(2), 1997, pp. 137-148

Authors: HARASYM TO TARDI P LONGMAN SA ANSELL SM BALLY MB CULLIS PR CHOI LSL

Citation: To. Harasym et al., POLY(ETHYLENE GLYCOL)-MODIFIED PHOSPHOLIPIDS PREVENT AGGREGATION DURING COVALENT CONJUGATION OF PROTEINS TO LIPOSOMES, Bioconjugate chemistry, 6(2), 1995, pp. 187-194

Authors: WEBB MS HARASYM TO MASIN D BALLY MB MAYER LD

Citation: Ms. Webb et al., SPHINGOMYELIN-CHOLESTEROL LIPOSOMES SIGNIFICANTLY ENHANCE THE PHARMACOKINETIC AND THERAPEUTIC PROPERTIES OF VINCRISTINE IN MURINE AND HUMANTUMOR-MODELS, British Journal of Cancer, 72(4), 1995, pp. 896-904